Paragon Vision Sciences
From The Press
Valeant Pharmaceuticals (VRX) Mulls Sale of Paragon Vision Sciences
Valeant Pharmaceuticals Intl (NYSE:VRX) is considering the possibility of selling Paragon Vision Sciences, its specialty contact lens manufacturing unit. The Canadian company contacted potential buyers, according to a report from Reuters based on information...
